Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for EGEN-001 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for platinum-resistant/refractory, paclitaxel-pretreated recurrent ovarian and peritoneal carcinoma; study terminated w…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
CLINICAL_TRIALS withdrawal · 2017-07-14Clinical Trial Update: Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy [NA]
A clinical trial evaluating oregovomab with or without cyclophosphamide in Stage III/IV ovarian epithelial cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 feasibility trial evaluating intraperitoneal chemotherapy for ovarian, fallopian tube, and primary peritoneal carcinomas has been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients [Phase 1]
A Phase 1 clinical trial update evaluating therapeutic targeting of stress factors in ovarian cancer; status is completed.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]
Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update on combination chemotherapy for stage III/IV ovarian epithelial cancer or primary peritoneal cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study evaluating the combination of irinotecan and bevacizumab in recurrent ovarian cancer (including fallopian tube cancer and pr…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer [Phase 2]
Phase 2 clinical trial evaluating selumetinib sulfate in women with recurrent low-grade ovarian or peritoneal serous carcinomas has complete…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]
Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; st…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for pazopanib/doxorubicin in relapsed platinum-sensitive or resistant ovarian, fallopian tube, or primary peritoneal a…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Ramucirumab in Ovarian Cancer [Phase 2]
Phase 2 trial update of ramucirumab in ovarian cancer and related gynecologic cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallop…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer [NA]
Clinical trial update for hyperthermic intraperitoneal chemotherapy using carboplatin in first recurrence ovarian cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels [Phase 2]
Phase 2 trial evaluating the efficacy of Å6 in ovarian cancer patients who have completed first-line chemotherapy and show rising CA-125; th…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without paclitaxel and carboplatin for recurrent ovarian, fallopian tube, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Phase 2]
The Phase 2 study evaluating the combination of Iressa (gefitinib) and Anastrozole (Arimidex) in ovarian, peritoneal, and tubal carcinomas h…